Drawing for BIOPRAX

USPTO serial 97805563

BIOPRAX

Reviewed by CopyMark Law Group

Reg. 8487025Status 700Registered
Filing date
Status date
Registration date
Oct 6, 2026
Examiner
ZARICK, DIANA G
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIOPRAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

SARA M. DORCHAK

SARA M. DORCHAK BARCLAY DAMON LLP1270 AVENUE OF THE AMERICAS, STE 501NEW YORK, NY 10020United States

Goods and services

ClassDescriptionStatusFirst use
010Medical devices for the treatment of infection for use on implanted orthopedic implants and other implanted medical implements; medical devices for infection control for use on implanted orthopedic implants and other implanted medical implements; electrical medical device for use on implanted orthopedic implants and other implanted medical implements for the reduction of the growth of microbes and biofilms on the surface of an implanted object for infection treatment; medical devices for the reduction and disruption of biofilms for infection treatment for use on implanted orthopedic implants and other implanted medical implements; medical devices comprised of LCD display, needles, and electrodes for the reduction of microbes and biofilms for infection treatment; medical devices comprised of LCD display, needles, and electrodes for the reduction of microbes and biofilms on orthopedic and medical implants and devices for infection treatment; medical devices comprised of LCD display, needles, and electrodes used on implanted orthopedic implants and other implanted medical implants for reduction and disruption of microbes and biofilms; medical devices for use on implanted orthopedic implants and other implanted medical implements used for orthopedic and medical implant infection controlACTIVESep 15, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 6, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 17, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 17, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 17, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 17, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 17, 2026ALIEASSIGNED TO LIE—
Sep 16, 2026NREVNOTICE OF REVIVAL - E-MAILED—
Sep 16, 2026PGRRPETITION GRANTED - RESPONSE RECEIVED—
Sep 11, 2026APETASSIGNED TO PETITION STAFF—
Aug 29, 2026PROATEAS PETITION TO REVIVE RECEIVED—
Aug 25, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 25, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 11, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 11, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 11, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 12, 2025IUAFUSE AMENDMENT FILED—
Nov 12, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 13, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 12, 2025EX1GSOU EXTENSION 1 GRANTED—
May 12, 2025EXT1SOU EXTENSION 1 FILED—
May 12, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 3, 2024TMBNTTAB RELEASE CASE TO TRADEMARKS—
Oct 3, 2024OP.TOPPOSITION TERMINATED NO. 999999—
Oct 3, 2024OP.DOPPOSITION DISMISSED NO. 999999—
Jul 7, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jul 3, 2024OP.IOPPOSITION INSTITUTED NO. 999999—
Feb 5, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 5, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 5, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 5, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 9, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 9, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 20, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 4, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 4, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Dec 4, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 4, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 4, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 21, 2023DOCKASSIGNED TO EXAMINER—
Mar 12, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 25, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance